NCT01181609View on ClinicalTrials.gov

A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Colorectal Cancer

Interventions

DRUG

bevacizumab [Avastin]

5 mg/kg every 2 weeks or 7.5 mg/kg every 3 weeks according to the chemotherapy regimen

Trial Locations (16)

13005

Marseille

21079

Dijon

25030

Besançon

31052

Toulouse

34298

Montpellier

44805

Saint-Herblain

49933

Angers

51092

Reims

68024

Colmar

69310

Pierre-Bénite

75679

Paris

85925

La Roche-sur-Yon

92104

Boulogne-Billancourt

92200

Neuilly-sur-Seine

92210

Saint-Cloud

06189

Nice

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01181609 - A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | Biotech Hunter | Biotech Hunter